Volume 5, Issue 3 (2014)

PDF

Dapagliflozin: A Newly Approved SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Ann Marie Ruhe, Rachel Muhlenkamp, Austin Brown, Emily Blum, and Sandra L. Hrometz

PDF

lbrutinib (lmbruvica™) for Treatment of Mantle Cell Lymphoma
Brittany Crowe, Joy Hoffman, Hannah Stewart, Alison Steinbrunner, and Mark E. Olah

PDF

Advances in Treatment of Chronic Hepatitis C Virus (HCV) Infection
Halle Orlinski, Kimberly Loughlin, Haley Armstrong, Emily Blum, and Andrew M. Roecker

PDF

Crohn's Disease: Management, Emerging Therapies and the Role of the Pharmacist
Sarah Turley, Tiffany Kneuss, Lydia Suchecki, Alison Steinbrunner, and Kristen Timperman

PDF

New Cholesterol Guidelines: An Update for Pharmacists
Emily Limberg, Benjamin Finley, Stacy Henthorne, Sarah Kradel, and David Bright

PDF

Pharmacists' Role in Emergency Preparedness and Response
Jamie Kellner, Ginny Daniels, Maureen Moynihan, Joseph Stecyk, Kasie Bellmann, and Natalie DiPietro

PDF

Pharmacogenetics: CYPs, NAT2 and 5-HTT Related to Antidepressants
Molly Kulp, Armond Cosiano, Kevin Krivanek, Amanda Lanker, Taylor Roberson, and David F. Kisor

PDF

Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents: Benefits and Challenges
Kaila Bollinger, Albert Bui, Adam Smith, Kelsey Fink, and Manoranjan D'Souza